16 décembre 2025

On 10 December 2025, Galderma (SIX: GALD), the pure-play dermatology category leader, has successfully issued a single tranche CHF 175 million guaranteed bond, The bond has a maturity of 5 years and carries a fixed-rate annual coupon of 0.9425%. The bond will be listed on the SIX Swiss Exchange. The net proceeds from the transaction will be used to partially refinance Galderma’s existing bank term loan issued at its initial public offering (IPO) in March 2024, as well as for general corporate purposes. This marks the company’s third CHF-bond issuance since listing.

The transaction was led by BNP Paribas and UBS as joint lead managers.

Walder Wyss advised the banking syndicate. The team was led by David Borer (Partner, Capital Markets) and included Laura Tarenzi (Senior Associate, Capital Markets), Ganna Schneuwly (Transaction Manager, Capital Markets) and Maurus Winzap (Partner, Tax).